In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported.
Tauangtham AnekpuritanangMatthew M KlairmontJoel GradowskiKohei HagiwaraNathanael G BaileyPranil ChandraYiwei LiuHeather L MulderJohn EastonJinghui ZhangMichael G MartinAnna B OwczarczykJennifer B DunlapGuang FanRichard D PressPhilipp W RaessPublished in: Blood advances (2022)